🔎 Trials Near Me

Home › Cancro metastatico › Ohio

Studi clinici su Cancro metastatico nello stato di Ohio

62 studi su Cancro metastatico cercano partecipanti presso sedi nello stato di Ohio.

Città nello stato di Ohio

Testo ufficiale dello studio (inglese)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • OhioHealth O'Bleness Hospital, Athens
  • UH Seidman Cancer Center at UH Avon Health Center, Avon
  • UHHS-Chagrin Highlands Medical Center, Beachwood
  • e altri 39
In reclutamentoFase 2
Tutte le età · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • The Cleveland Clinic Taussig Cancer Center, Cleveland
In reclutamentoFase 1/2
Età 12 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT04585750

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • University Hospitals Cleveland Medical Center, Cleveland
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06465069

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  • Taylor Cancer Research Center, Maumee
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07562152

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

  • Ohio State University Comprehensive Cancer Center, Columbus
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05372614

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

  • University Hospitals Cleveland Medical Center, Cleveland
  • Cleveland Clinic, Cleveland
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06234605

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

  • ALX Center 10, Columbus
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07085091

A Study of ASP3082 in Adults With Advanced Solid Tumors

  • Case Western, Cleveland
  • Taylor Cancer Research Center, Maumee
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT05382559

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  • University Hospitals Cleveland Medical Center, Cleveland
  • The Ohio State University Comprehensive Cancer Center, Columbus
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT06943755

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • University of Cincinnati Cancer Center-West Chester, West Chester
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT05803382

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • Oncology Hematology Care - Eastgate, Cincinnati
  • University Hospitals Cleveland Medical Center, Cleveland
  • Oncology Hematology Care Clinical Trials, LLC, Fairfield
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07222800

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • Aultman Hospital, Canton
  • Aultman Medical Group Hematology and Oncology, Canton
  • Oncology Hematology Care Clinical Trials, Cincinnati
  • e altri 7
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07222566

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

  • Research Site, Cincinnati
  • Research Site, Cincinnati
  • Research Site, Cleveland
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

  • Gabrail Cancer Center, Canton
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07007559

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

  • Ohio State University, Columbus
In reclutamentoFase 1/2
Età 12 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT05118789

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  • University of Cincinnati Medical Center, Cincinnati
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • Cleveland Clinic Akron General, Akron
  • Gabrail Cancer Center, Canton
  • University Hospitals Cleveland Medical Center, Cleveland
  • e altri 3
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07174336

SLV-154 Treatment of Advanced Cancers

  • University Hospitals Cleveland Medical Center, Cleveland
  • The James Outpatient Care West Center, Columbus
In reclutamentoFase 1
Età 12 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06771219

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • Miami Valley Hospital South, Centerville
  • University of Cincinnati Medical Center, Cincinnati
  • Oncology Hematology Care Inc, Cincinnati
  • e altri 7
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07213804

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

  • University Hospitals Cleveland Medical Center, Cleveland
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 set 2026 · NCT06566079

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

  • Clinical Study Site, Columbus
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 10 set 2026 · NCT07335497

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Miami Valley Hospital South, Centerville
  • USO - Oncology Hematology Care, Cincinnati
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06119581

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

  • Ohio State University Hospital, Columbus
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06561685

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

  • Ohio State University Comprehensive Cancer Center, Columbus
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 4 set 2026 · NCT06311214

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

  • Cleveland Clinic, Cleveland
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT04913285

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • Gabrail Cancer & Research Center, Canton
  • Cleveland Clinic, Cleveland
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT06072612

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

  • Cleveland Clinic, Cleveland
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 ago 2026 · NCT07029399

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

  • Avenzo Therapeutics Recruiting Site, Cleveland
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT07193511

Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors

  • Ohio State University Comprehensive Cancer Center, Columbus
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 ago 2026 · NCT05687136

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

  • Ohio State University, Columbus
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 ago 2026 · NCT06769698

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

  • University of Cincinnati Medical Center (UCMC), Cincinnati
  • The Ohio State University (OSU), Columbus
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT05614739

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
  • Cleveland Clinic, Cleveland
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 ago 2026 · NCT05919264

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

  • Ohio State University Comprehensive Cancer Center, Columbus
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 ago 2026 · NCT05687110

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Oncology Hematology Care Primary, Cincinnati
  • Taylor Cancer Research Center, Maumee
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 lug 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  • Research Site, Cincinnati
  • Research Site, Cleveland
  • Research Site, Cleveland
  • e altri 4
In reclutamentoFase 3
Età 18 e oltre · Donne · Aggiornato il 29 lug 2026 · NCT07044336

A Study of ASP1002 in Adults for Treatment of Solid Tumors

  • University Hospitals of Cleveland, Cleveland
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 lug 2026 · NCT05719558

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

  • The Ohio State University Comprehensive Cancer Center, Columbus
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 9 lug 2026 · NCT07103018

A Study of PYX-201 in Advanced Solid Tumors

  • University of Cincinnati Medical Center, Cincinnati
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 giu 2026 · NCT05720117

A Study of LY4175408 in Participants With Advanced Cancer

  • The Ohio State University (OSU) Wexner Medical Center, Columbus
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 giu 2026 · NCT07046923

REMASTer: REcurrent Brain Metastases After SRS Trial

  • Cleveland Clinic, Cleveland
  • Kettering Health, Kettering
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 giu 2026 · NCT05124912

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.